ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,850.14
-0.78%
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs Yen
155.633
0.57%
Brent Oil
83.565
0.84%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Eton Pharmaceuticals Inc (ETON)

  7. Eton Pharmaceuticals Inc (ETON) ニュース

ETON

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ETON
日付受信時刻ニュースソース見出しコード企業名
2024/05/0205 : 05GlobeNewswire Inc.Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
2024/04/3020 : 00GlobeNewswire Inc.Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
2024/04/3005 : 30GlobeNewswire Inc.Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ETONEton Pharmaceuticals Inc
2024/03/2215 : 00GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaNASDAQ:ETONEton Pharmaceuticals Inc
2024/03/1505 : 01GlobeNewswire Inc.Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
2024/03/0106 : 01GlobeNewswire Inc.Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024NASDAQ:ETONEton Pharmaceuticals Inc
2024/02/2120 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/2120 : 50GlobeNewswire Inc.Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/1606 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/1606 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/1606 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/0220 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
2024/02/0220 : 50GlobeNewswire Inc.Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone CapsulesNASDAQ:ETONEton Pharmaceuticals Inc
2023/11/1006 : 25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
2023/11/1006 : 01GlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
2023/10/3019 : 50GlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023NASDAQ:ETONEton Pharmaceuticals Inc
2023/10/1821 : 00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
2023/10/0419 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
2023/10/0419 : 50GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product NitisinoneNASDAQ:ETONEton Pharmaceuticals Inc
2023/08/2319 : 50GlobeNewswire Inc.Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
2023/08/1105 : 20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
2023/08/1105 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
2023/08/1105 : 01GlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
2023/08/0205 : 05GlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023NASDAQ:ETONEton Pharmaceuticals Inc
2023/07/1805 : 05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
2023/06/2820 : 42Dow Jones NewsEton Pharma Gets FDA Complete Response Letter for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
2023/06/2819 : 56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
2023/06/2819 : 50GlobeNewswire Inc.Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
2023/06/1605 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
2023/06/1405 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ETON

最近閲覧した銘柄

NASDAQ
AAPL
Apple
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
NYSE
AXP
American Express
USI
USTECH100
US Tech 100
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有